Condition
Adrenocortical Cancer
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Terminated1
Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04897321Phase 1Recruiting
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
NCT04447014Terminated
Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)
NCT03517332Unknown
Circulating Tumor DNA Exposure in Peripheral Blood
Showing all 3 trials